ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

CTEC Convatec Group Plc

283.60
2.60 (0.93%)
18 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Convatec Group Plc LSE:CTEC London Ordinary Share GB00BD3VFW73 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  2.60 0.93% 283.60 282.20 282.40 283.60 280.40 282.40 4,539,270 16:35:05
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Med, Dental, Hosp Eq-whsl 2.14B 130.3M 0.0636 44.40 5.79B

ConvaTec Group PLC Scrip Dividend - calculation price (7558Q)

14/09/2017 10:09am

UK Regulatory


Convatec (LSE:CTEC)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Convatec Charts.

TIDMCTEC

RNS Number : 7558Q

ConvaTec Group PLC

14 September 2017

Scrip Dividend - calculation price

Reading, United Kingdom (14 September 2017)

On 3 August 2017 ConvaTec Group Plc ("ConvaTec" or "the Company") declared an interim dividend of 1.4 cents per share (the "interim dividend"). This interim dividend is to be paid on 20 October 2017 to shareholders on the share register as at 8 September 2017 ("record date"). The dividend is payable in cash in sterling to holders of ordinary shares. On 11 September 2017 the Company announced that a scrip dividend scheme will be made available for this interim dividend allowing shareholders to elect to receive their dividend in the form of new ordinary shares.

The "Calculation Price" for the issue of new ordinary shares under the scrip dividend scheme is:

272 pence for each new ordinary share

This is equivalent to 1 new share for approximately 256.6 shares held prior to the ex-dividend date of 7 September 2017

The Calculation Price is the average of the middle market quotations of a ConvaTec share, derived from the London Stock Exchange Daily Official List, for the five consecutive business days from 7 September to 13 September 2017 (inclusive).

The latest date for receipt of elections to participate in the scrip dividend scheme for this interim dividend is 29 September 2017. Shareholders must return their mandate form by 5pm (GMT) or otherwise input their CREST elections to be received by the Company's registrar, Computershare, by 3pm (GMT) on 29 September 2017. Elections received after this deadline will apply to subsequent dividends only. Unless revoked by you, your scrip dividend election will apply for all future dividends for which a scrip dividend is offered. Evergreen elections for CREST shareholders cannot be accepted and elections will revert to cash by default after the payment of each dividend.

Details of the scrip dividend scheme are available at www.convatecgroup.com/investors

TIMETABLE

Key dates in respect of the scrip dividend scheme for the interim dividend are:

 
 Ex-dividend Date                        7 September 2017 
 Record Date                             8 September 2017 
 Scrip calculation price determined        7-13 September 
                                         2017 (inclusive) 
 Scrip calculation price available      14 September 2017 
  and announced 
 Mandate delivery deadline for Shares     3.00 p.m. on 29 
  held in uncertificated form              September 2017 
 Mandate delivery deadline for Shares     5.00 p.m. on 29 
  held in certificated form                September 2017 
 Announcement of the total amount          5 October 2017 
  of new shares to be issued 
 Dividend payment date                    20 October 2017 
 Dispatch of statement in accordance      20 October 2017 
  with section 7 of Scheme Rules and 
  share certificates, CREST accounts 
  credited/updated, and first day 
  of dealings in New Shares 
 

Enquiries

Media

   Bobby Leach, VP Group Corporate Affairs, ConvaTec                    +44 (0)7770 842 226 

Alastair Elwen, Finsbury +44 (0)207 251 3801

Analysts and Investors

   John Crosse, VP Investor Relations, ConvaTec                             +44 (0)7500 141 435 
   Kirsty Law, Director Investor Relations, ConvaTec                         +44 (0)7470 909 582 

investorrelations@convatec.com

About ConvaTec

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. ConvaTec's products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com where a copy of this announcement can also be found.

# # #

This information is provided by RNS

The company news service from the London Stock Exchange

END

DIVOKQDKCBKKCCD

(END) Dow Jones Newswires

September 14, 2017 05:09 ET (09:09 GMT)

1 Year Convatec Chart

1 Year Convatec Chart

1 Month Convatec Chart

1 Month Convatec Chart

Your Recent History

Delayed Upgrade Clock